Compare RYAN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RYAN | TECH |
|---|---|---|
| Founded | 2010 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8B | 11.4B |
| IPO Year | 2021 | 1995 |
| Metric | RYAN | TECH |
|---|---|---|
| Price | $41.91 | $72.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 11 |
| Target Price | $50.88 | ★ $71.82 |
| AVG Volume (30 Days) | 1.4M | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.48% | 0.62% |
| EPS Growth | N/A | ★ 152.17 |
| EPS | N/A | ★ 1.16 |
| Revenue | ★ $3,051,126,000.00 | $1,215,039,000.00 |
| Revenue This Year | $15.78 | $2.49 |
| Revenue Next Year | $12.49 | $6.40 |
| P/E Ratio | $86.72 | ★ $62.43 |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $29.28 | $43.20 |
| 52 Week High | $59.19 | $72.62 |
| Indicator | RYAN | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 64.96 |
| Support Level | $40.43 | $71.89 |
| Resistance Level | $43.10 | $72.62 |
| Average True Range (ATR) | 1.33 | 0.18 |
| MACD | -0.23 | -0.20 |
| Stochastic Oscillator | 25.36 | 57.29 |
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.